BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 28842360)

  • 1. Notch-out for breast cancer therapies.
    Lamy M; Ferreira A; Dias JS; Braga S; Silva G; Barbas A
    N Biotechnol; 2017 Oct; 39(Pt B):215-221. PubMed ID: 28842360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch signaling pathway as a therapeutic target in breast cancer.
    Al-Hussaini H; Subramanyam D; Reedijk M; Sridhar SS
    Mol Cancer Ther; 2011 Jan; 10(1):9-15. PubMed ID: 20971825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch signaling in breast cancer: From pathway analysis to therapy.
    Krishna BM; Jana S; Singhal J; Horne D; Awasthi S; Salgia R; Singhal SS
    Cancer Lett; 2019 Oct; 461():123-131. PubMed ID: 31326555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.
    Zhou W; Wang G; Guo S
    Biochim Biophys Acta; 2013 Dec; 1836(2):304-20. PubMed ID: 24183943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling in breast cancer and tumor angiogenesis: cross-talk and therapeutic potentials.
    Shi W; Harris AL
    J Mammary Gland Biol Neoplasia; 2006 Jan; 11(1):41-52. PubMed ID: 16947085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives.
    Moore G; Annett S; McClements L; Robson T
    Cells; 2020 Jun; 9(6):. PubMed ID: 32575680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch signaling and its role in breast cancer.
    Wu F; Stutzman A; Mo YY
    Front Biosci; 2007 May; 12():4370-83. PubMed ID: 17485381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch signaling in the hematopoietic system.
    Sandy AR; Maillard I
    Expert Opin Biol Ther; 2009 Nov; 9(11):1383-98. PubMed ID: 19743891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
    Zardawi SJ; O'Toole SA; Sutherland RL; Musgrove EA
    Histol Histopathol; 2009 Mar; 24(3):385-98. PubMed ID: 19130408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model.
    Efferson CL; Winkelmann CT; Ware C; Sullivan T; Giampaoli S; Tammam J; Patel S; Mesiti G; Reilly JF; Gibson RE; Buser C; Yeatman T; Coppola D; Winter C; Clark EA; Draetta GF; Strack PR; Majumder PK
    Cancer Res; 2010 Mar; 70(6):2476-84. PubMed ID: 20197467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures.
    Locatelli M; Curigliano G
    Curr Opin Oncol; 2017 Nov; 29(6):411-427. PubMed ID: 28914645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
    Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
    Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting notch signaling pathway in cancer: clinical development advances and challenges.
    Takebe N; Nguyen D; Yang SX
    Pharmacol Ther; 2014 Feb; 141(2):140-9. PubMed ID: 24076266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.
    Hirose H; Ishii H; Mimori K; Ohta D; Ohkuma M; Tsujii H; Saito T; Sekimoto M; Doki Y; Mori M
    Oncol Rep; 2010 Jan; 23(1):35-43. PubMed ID: 19956862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Notch degradation system provides promise for breast cancer therapeutics.
    Liu J; Shen JX; Wen XF; Guo YX; Zhang GJ
    Crit Rev Oncol Hematol; 2016 Aug; 104():21-9. PubMed ID: 27263934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Notch signaling and breast cancer.
    Reedijk M
    Adv Exp Med Biol; 2012; 727():241-57. PubMed ID: 22399352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy.
    Li L; Tang P; Li S; Qin X; Yang H; Wu C; Liu Y
    Med Oncol; 2017 Sep; 34(10):180. PubMed ID: 28918490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
    Yamaguchi N; Oyama T; Ito E; Satoh H; Azuma S; Hayashi M; Shimizu K; Honma R; Yanagisawa Y; Nishikawa A; Kawamura M; Imai J; Ohwada S; Tatsuta K; Inoue J; Semba K; Watanabe S
    Cancer Res; 2008 Mar; 68(6):1881-8. PubMed ID: 18339869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Notch signalling in ovarian angiogenesis.
    Xie Q; Cheng Z; Chen X; Lobe CG; Liu J
    J Ovarian Res; 2017 Mar; 10(1):13. PubMed ID: 28284219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.